Free Trial
NYSE:ELAN

Elanco Animal Health (ELAN) Stock Price, News & Analysis

Elanco Animal Health logo
$18.44 -0.05 (-0.28%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Elanco Animal Health Stock (NYSE:ELAN)

Key Stats

Today's Range
$18.37
$18.62
50-Day Range
$13.36
$18.52
52-Week Range
$8.02
$18.87
Volume
7.10 million shs
Average Volume
5.56 million shs
Market Capitalization
$9.18 billion
P/E Ratio
21.51
Dividend Yield
N/A
Price Target
$17.33
Consensus Rating
Moderate Buy

Company Overview

Elanco Animal Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
57th Percentile Overall Score

ELAN MarketRank™: 

Elanco Animal Health scored higher than 57% of companies evaluated by MarketBeat, and ranked 465th out of 945 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Elanco Animal Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.78, and is based on 5 buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Elanco Animal Health has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Elanco Animal Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Elanco Animal Health are expected to decrease by -2.20% in the coming year, from $0.91 to $0.89 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Elanco Animal Health is 21.57, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 28.72.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Elanco Animal Health is 21.57, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 30.73.

  • Price to Earnings Growth Ratio

    Elanco Animal Health has a PEG Ratio of 3.32. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Elanco Animal Health has a P/B Ratio of 1.36. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Elanco Animal Health's valuation and earnings.
  • Percentage of Shares Shorted

    4.87% of the float of Elanco Animal Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Elanco Animal Health has a short interest ratio ("days to cover") of 4.1.
  • Change versus previous month

    Short interest in Elanco Animal Health has recently increased by 1.65%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Elanco Animal Health does not currently pay a dividend.

  • Dividend Growth

    Elanco Animal Health does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.87% of the float of Elanco Animal Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Elanco Animal Health has a short interest ratio ("days to cover") of 4.1.
  • Change versus previous month

    Short interest in Elanco Animal Health has recently increased by 1.65%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Elanco Animal Health has a news sentiment score of 0.71. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 15 news articles for Elanco Animal Health this week, compared to 9 articles on an average week.
  • Search Interest

    Only 4 people have searched for ELAN on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added Elanco Animal Health to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Elanco Animal Health insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.89% of the stock of Elanco Animal Health is held by insiders.

  • Percentage Held by Institutions

    97.48% of the stock of Elanco Animal Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Elanco Animal Health's insider trading history.
Receive ELAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Elanco Animal Health and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ELAN Stock News Headlines

Think you missed gold’s boom? Think again
If you've been watching gold's historic run and wondering if it's too late… I've got good news. Because there's a $15 fund tied directly to gold's surge that's still paying massive income… Up to 64% annually — with payouts every 30 days.tc pixel
Elanco buys GM Stamping Plant site in Indianapolis
See More Headlines

ELAN Stock Analysis - Frequently Asked Questions

Elanco Animal Health's stock was trading at $12.11 at the start of the year. Since then, ELAN stock has increased by 53.2% and is now trading at $18.5550.

Elanco Animal Health Incorporated (NYSE:ELAN) released its earnings results on Thursday, August, 7th. The company reported $0.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.20 by $0.06. The business's revenue was up 4.8% on a year-over-year basis.
Read the conference call transcript
.

Elanco Animal Health (ELAN) raised $1.4 billion in an initial public offering (IPO) on Thursday, September 20th 2018. The company issued 62,900,000 shares at a price of $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Barclays, BNP PARIBAS, BofA Merrill Lynch, Citigroup, Credit Suisse, Deutsche Bank Securities, Evercore ISI, Cowen, Academy Securities, Drexel Hamilton, Mischler Financial Group, Ramirez and The Williams Capital Group were co-managers.

Elanco Animal Health's top institutional shareholders include Dodge & Cox (16.69%), Primecap Management Co. CA (10.42%), Black Creek Investment Management Inc. (3.87%) and State Street Corp (1.84%). Insiders that own company stock include R David Hoover, Jeffrey N Simmons, Lawrence Erik Kurzius, Michael J Harrington, John P Bilbrey and Rajeev A Modi.
View institutional ownership trends
.

Shares of ELAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Elanco Animal Health investors own include Salesforce (CRM), Home Depot (HD), Chevron (CVX), Pfizer (PFE), Bank of America (BAC), QUALCOMM (QCOM) and AbbVie (ABBV).

Company Calendar

Last Earnings
8/07/2025
Today
8/28/2025
Next Earnings (Estimated)
11/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED - OUTP/HM CRE
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSE:ELAN
CIK
1739104
Fax
N/A
Employees
9,000
Year Founded
N/A

Price Target and Rating

High Price Target
$19.00
Low Price Target
$13.00
Potential Upside/Downside
-6.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.78
Research Coverage
9 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.86
Trailing P/E Ratio
21.45
Forward P/E Ratio
20.32
P/E Growth
3.32
Net Income
$338 million
Net Margins
9.68%
Pretax Margin
13.23%
Return on Equity
7.04%
Return on Assets
3.45%

Debt

Debt-to-Equity Ratio
0.61
Current Ratio
2.60
Quick Ratio
1.40

Sales & Book Value

Annual Sales
$4.44 billion
Price / Sales
2.07
Cash Flow
$2.33 per share
Price / Cash Flow
7.94
Book Value
$13.64 per share
Price / Book
1.36

Miscellaneous

Outstanding Shares
496,810,000
Free Float
492,392,000
Market Cap
$9.19 billion
Optionable
Optionable
Beta
1.66

Social Links

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NYSE:ELAN) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners